The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Landscape of somatic mutations in 560 breast cancer whole-genome sequences
Open accessAbstract
We analysed whole-genome sequences of 560 breast cancers to advance understanding of the driver mutations conferring clonal advantage and the mutational processes generating somatic mutations. We found that 93 protein-coding cancer genes carried probable driver mutations. Some non-coding regions exhibited high mutation frequencies, but most have distinctive structural features probably causing elevated mutation rates and do not contain driver mutations. Mutational signature analysis was extended to genome rearrangements and revealed twelve base substitution and six rearrangement signatures. Three rearrangement signatures, characterized by tandem duplications or deletions, appear associated with defective homologous-recombination-based DNA repair: one with deficient BRCA1 function, another with deficient BRCA1 or BRCA2 function, the cause of the third is unknown. This analysis of all classes of somatic mutation across exons, introns and intergenic regions highlights the repertoire of cancer genes and mutational processes operating, and progresses towards a comprehensive account of the somatic genetic basis of breast cancer. Whole-genome sequencing of tumours from 560 breast cancer cases provides a comprehensive genome-wide view of recurrent somatic mutations and mutation frequencies across both protein coding and non-coding regions; several mutational signatures in these cancer genomes are associated with BRCA1 or BRCA2 function and defective homologous-recombination-based DNA repair. This study reports whole-genome sequencing of tumours and normal tissue from 560 breast cancer cases, providing a comprehensive genome-wide view of recurrent somatic mutations and mutation frequencies across both protein coding and non-coding regions. The authors analyse mutational signatures in these cancer genomes, including a new investigation of rearrangement mutational processes, and find several that are associated with BRCA1 or BRCA2 function and defective homologous-recombination-based DNA repair. They also find mutational signatures showing distinct DNA replication strand biases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, BRCA inactivation is known to promote genomic instability through homologous recombination deficiencies in several solid tumors such as breast and ovarian cancer.47”
From Evolution of Multiple Myeloma from a Genomic Perspective (2026) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, some mutational footprints were found to be associated with BRCA1/2 deficiency, namely deletions with flanking microhomology, as well as several “mutational signatures” including two COSMIC single nucleotide variant (SNV) signatures and two structural variant (SV) signatures8.”
From Pan-cancer landscape of homologous recombination deficiency. (2020) · cites this paper as [8]
In the citing paper
“These genomic features in the SCAN-B TNBC cohort were comparable to a previously reported WGS cohort8”
From Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study (2019) · cites this paper as [8]
In the citing paper
“Five substitution and five rearrangement signatures [8, 9] were identified”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Seventy-nine out of the 93 previously identified BC driver genes [9] were mutated”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Despite the role of TP53, ATM and CHEK2 in DNA-damage signalling and double-strand breaks detection, these tumours do not show evidence of BRCA-deficient signatures, as previously described [9, 13, 19], but instead they harbour highly complex clustered chromosomal rearrangements.”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“The variant was not reported in gnomAD or in the 560 BC genomes cohort [9] and is described by ClinVar (Variation ID: 135816) as ‘Class 3 Uncertain significance’”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“Loss of function of BRCA1, BRCA2 and PALB2 yield a high mutation burden and specific signatures inferring defective HR [7, 9, 10, 13].”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
In the citing paper
“These clustered events coincided with amplifications of known BC oncogenes (e.g. ZNF217, ERBB2, CCND1, MYC) [9]”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,989
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Self-citationNishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,239
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citationVelvet: Algorithms for de novo short read assembly using de Bruijn graphsPreprint
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,575
Self-citationThe genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Self-citationConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,645
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Cited by
Sorted by citations
Items 701–800 of 1,002
Homologous recombination deficiency: how genomic signatures are generated
Setton, J. S., Reis-Filho, J. S., & Powell, S. N. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2021.01.002 · Cited by 29
Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer
Akçakanat, A., Zheng, X., Pico, C. X. C., Kim, T., Chen, K., Korkut, A., Şahin, A. A., Holla, V. R., Tarco, E., Singh, G., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4048 · Cited by 33
Gadd, S., Huff, V., Skol, A. D., Renfro, L. A., Fernandez, C. V., Mullen, E. A., Jones, C. D., Hoadley, K. A., Yap, K. L., Ramirez, N. C., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100644 · Cited by 35
Georgakopoulos‐Soares, I., Chan, C. S. Y., Ahituv, N., & Hemberg, M. (2022) · Genome biology · doi:10.1186/s13059-022-02727-6 · Cited by 34
The Long and the Short of It: NEAT1 and Cancer Cell Metabolism
Smith, N. E., Spencer-Merris, P., Fox, A. H., Petersen, J., & Michael, M. (2022) · Cancers · doi:10.3390/cancers14184388 · Cited by 33
Identification of coding and non-coding mutational hotspots in cancer genomes
Piraino, S. W., & Furney, S. J. (2017) · BMC Genomics · doi:10.1186/s12864-016-3420-9 · Cited by 32
Dysregulated expression of repetitive DNA in ER+/HER2- breast cancer
Yandım, C., & Karakülah, G. (2019) · Cancer Genetics · doi:10.1016/j.cancergen.2019.09.002 · Cited by 31
Dong, H., Ding, L., Zhou, T.-R., Yan, T., Li, J., & Liang, C. (2022) · Asian Journal of Andrology · doi:10.4103/aja202259 · Cited by 33
Progesterone from ovulatory menstrual cycles is an important cause of breast cancer
Bennink, H. J. T. C., Schultz, I. J., Schmidt, M., Jordan, V. C., Briggs, P., Egberts, J. F. M., Gemzell‐Danielsson, K., Kiesel, L., Kluivers, K. B., Krijgh, J., et al. (2023) · Breast Cancer Research · doi:10.1186/s13058-023-01661-0 · Cited by 34
Crosstalk between SUMOylation and other post-translational modifications in breast cancer
Wei, B., Yang, F., Yu, L., & Qiu, C. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00624-3 · Cited by 36
Kim, J., Lee, E., Park, K., Park, W., Jung, H. H., Ahn, J. S., Im, Y., & Park, Y. H. (2017) · Oncotarget · doi:10.18632/oncotarget.15881 · Cited by 33
Roelofs, C., Hollande, F., Redvers, R. P., Anderson, R. L., & Mérino, D. (2019) · Biochemical Society Transactions · doi:10.1042/bst20180375 · Cited by 32
Platinum salts in the treatment of BRCA-associated breast cancer: A true targeted chemotherapy?
Torrisi, R., Zuradelli, M., Agostinetto, E., Masci, G., Losurdo, A., Sanctis, R. D., & Santoro, A. (2019) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2019.01.016 · Cited by 32
Mutational Processes in Hepatocellular Carcinoma: The Story of Aristolochic Acid
Nault, J., & Letouzé, E. (2019) · Seminars in liver disease (Print) · doi:10.1055/s-0039-1685516 · Cited by 27
Imprint of parity and age at first pregnancy on the genomic landscape of subsequent breast cancer
Nguyen, B., Venet, D., Lambertini, M., Desmedt, C., Salgado, R., Horlings, H. M., Rothé, F., & Sotiriou, C. P. (2019) · Breast Cancer Research · doi:10.1186/s13058-019-1111-6 · Cited by 32
Self-citationKnutsen, E., Lellahi, S. M., Aure, M. R. R., Nord, S., Fismen, S., Larsen, K. B., Gabriel, M. T., Hedberg, A., Bjørklund, S. S., Geisler, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-57759-4 · Cited by 32
Self-citationCapicua restricts cancer stem cell-like properties in breast cancer cells
Yoe, J., Kim, D., Kim, S., & Lee, Y. (2020) · Oncogene · doi:10.1038/s41388-020-1230-7 · Cited by 32
Attenuation of p53 mutant as an approach for treatment Her2-positive cancer
Fedorova, O., Daks, A. A., Shuvalov, O. Y., Kizenko, A., Petukhov, A., Gnennaya, Y., & Barlev, N. A. (2020) · Cell Death Discovery · doi:10.1038/s41420-020-00337-4 · Cited by 37
Technological readiness and implementation of genomic‐driven precision medicine for complex diseases
Franks, P. W., Melén, E., Friedman, M., Sundström, J., Kockum, I. S., Klareskog, L., Almqvist, C., Bergen, S. E., Czene, K., Hägg, S., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13330 · Cited by 34
Ward, A. V., Anderson, S. M., & Sartorius, C. A. (2021) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-021-09505-3 · Cited by 35
Naeini, M. M., Newell, F., Aoude, L. G., Bonazzi, V., Patel, K., Lampe, G., Koufariotis, L. T., Lakis, V., Addala, V., Kondrashova, O., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-38891-x · Cited by 34
Tyran, M., Carbuccia, N., Garnier, S., Guillé, A., Adélaı̈de, J., Finetti, P., Touzlian, J., Viens, P., Tallet, A. R., Gonçalvès, A., et al. (2019) · Cancers · doi:10.3390/cancers11050665 · Cited by 32
Li, J., Wu, J., & Han, J. (2022) · Genes · doi:10.3390/genes14010044 · Cited by 32
Alternative splicing in prostate cancer progression and therapeutic resistance
Rawat, C., & Heemers, H. V. (2024) · Oncogene · doi:10.1038/s41388-024-03036-x · Cited by 32
Germline-mediated immunoediting sculpts breast cancer subtypes and metastatic proclivity
Houlahan, K. E., Khan, A., Greenwald, N. F., Sotomayor-Vivas, C., West, R. B., Angelo, M., & Curtis, C. N. (2024) · Science · doi:10.1126/science.adh8697 · Cited by 31
Translational Genomics: Practical Applications of the Genomic Revolution in Breast Cancer
Yates, L. R., & Desmedt, C. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2548 · Cited by 33
Self-citationYi, Z., Ma, F., Li, C., Chen, R., Yuan, L., Sun, X., Guan, X., Li, L., Liu, B., Guan, Y., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06327-4 · Cited by 31
Quist, J., Mirza, H., Cheang, M. C. U., Telli, M. L., O’Shaughnessy, J., Lord, C. J., Tutt, A. N. J., & Grigoriadis, A. E. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-18-0243 · Cited by 32
Self-citationYang, W., Zhao, X., Han, Y., Duan, L., Lü, X., Wang, X., Zhang, Y., Zhou, W. J., Liu, J., Zhang, H., et al. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0854-6 · Cited by 31
Liu, J., Adhav, R., Miao, K., Su, S. M., Mo, L., Chan, U. I., Zhang, X., Xu, J., Li, J., Shu, X., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18637-9 · Cited by 32
Multi-organ landscape of therapy-resistant melanoma
Liu, S., Dharanipragada, P., Lomeli, S. H., Wang, Y., Zhang, X., Yang, Z., Lim, R. J., Dumitras, C., Scumpia, P. O., Dubinett, S. M., et al. (2023) · Nature Medicine · doi:10.1038/s41591-023-02304-9 · Cited by 32
Luo, P., Lu, G., Fan, L., Zhong, X., Yang, H., Xie, R., Lv, Z., Lv, Q., Fu, D., Yang, L., et al. (2017) · Oncology Reports · doi:10.3892/or.2017.5449 · Cited by 31
Kato, T., Park, J.-H., Kiyotani, K., Ikeda, Y., Miyoshi, Y., & Nakamura, Y. (2017) · Oncotarget · doi:10.18632/oncotarget.18790 · Cited by 30
Genetic alterations in sporadic triple negative breast cancer
Pop, L., Cojocneanu, R., Pileczki, V., Morar-Bolba, G., Irimie, A., Lazar, V., Lombardo, C., Paradiso, A., & Berindan‐Neagoe, I. (2017) · The Breast · doi:10.1016/j.breast.2017.11.006 · Cited by 33
Co-regulated gene expression of splicing factors as drivers of cancer progression
Koedoot, E., Smid, M., Foekens, J. A., Martens, J. W. M., Dévédec, S. E. L., & van de Water, B. (2019) · Scientific Reports · doi:10.1038/s41598-019-40759-4 · Cited by 33
Self-citationPanchy, N. L., Azeredo-Tseng, C., Luo, M., Randall, N., & Hong, T. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01479 · Cited by 31
Wang, F.-Y., Yang, L.-M., Wang, S., Lu, H. J., Wang, X., Lu, Y., Ni, W., Liang, H., & Huang, K.-B. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c00285 · Cited by 30
Defects in homologous recombination repair behind the human diseases: FA and HBOC
Katsuki, Y., & Takata, M. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0221 · Cited by 32
Győrffy, B., Pongor, L. S., Bottai, G., Li, X., Budczies, J., Szabó, A., Hatzis, C., Pusztai, L., & Santarpia, L. (2018) · British Journal of Cancer · doi:10.1038/s41416-018-0030-0 · Cited by 32
Comprehensive genomic characterization of breast tumors with BRCA1 and BRCA2 mutations
Lal, A., Ramazzotti, D., Weng, Z., Liu, K., Ford, J. M., & Sidow, A. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0545-0 · Cited by 32
Werner, B., & Sottoriva, A. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006233 · Cited by 31
Jiang, L., Zheng, J., Kwan, J. S. H., Dai, S., Li, C., Li, M. J., Yu, B., TO, K. F., Sham, P. C., Zhu, Y., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz566 · Cited by 29
Bayati, M., Rabiee, H. R., Mehrbod, M., Vafaee, F., Ebrahimi, D., Forrest, A. R. R., & Alinejad‐Rokny, H. (2020) · Scientific Reports · doi:10.1038/s41598-020-58107-2 · Cited by 30
Homologous repair deficiency score for identifying breast cancers with defective DNA damage response
Min, A., Kim, K., Jeong, K., Choi, S., Kim, S., Suh, K. J., Lee, K.-H., Kim, S., & Im, S. (2020) · Scientific Reports · doi:10.1038/s41598-020-68176-y · Cited by 31
Page, C. L., Amuzu, S., Rahimi, K., Gotlieb, W. H., Ragoussis, J., & Tonin, P. N. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.08.005 · Cited by 30
Pan, J. W., Zabidi, M. M. A., Chong, B., Meng, M., Ng, P.-S., Hasan, S. N., Sandey, B., Bahnu, S., Rajadurai, P., Yip, C. H., et al. (2021) · International Journal of Cancer · doi:10.1002/ijc.33463 · Cited by 30
Self-citationA High-Dimensional Window into the Micro-Environment of Triple Negative Breast Cancer
Nederlof, I., Horlings, H. M., Curtis, C. N., & Kok, M. (2021) · Cancers · doi:10.3390/cancers13020316 · Cited by 33
GPR126 regulates colorectal cancer cell proliferation by mediating HDAC2 and GLI2 expression
Cui, H., Yu, W., Yu, M., Luo, Y., Yang, M., Cong, R., Chu, X., Gao, G., & Zhong, M. (2021) · Cancer Science · doi:10.1111/cas.14868 · Cited by 30
Somatic mutational profiles and germline polygenic risk scores in human cancer
Liu, Y., Gusev, A., Heng, Y. J., Alexandrov, L. B., & Kraft, P. L. (2022) · Genome Medicine · doi:10.1186/s13073-022-01016-y · Cited by 28
Self-citationDotolo, S., Abate, R. E., Roma, C., Guido, D., Preziosi, A., Tropea, B., Palluzzi, F., Giacò, L., & Normanno, N. (2022) · Biomedicines · doi:10.3390/biomedicines10092074 · Cited by 32
The repertoire of copy number alteration signatures in human cancer
Tao, Z., Wang, S., Wu, C., Wu, T., Zhao, X., Wei, N., Wang, G., Wang, J., Chen, J., Diao, K., et al. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad053 · Cited by 29
Capp, J. (2017) · International Journal of Cancer · doi:10.1002/ijc.30596 · Cited by 32
Computational Methods for Characterizing Cancer Mutational Heterogeneity
Vandin, F. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00083 · Cited by 31
Brustel, J., Kozik, Z., Gromak, N., Savic, V., & Sweet, S. M. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-21806-y · Cited by 33
Diagnostic utility of whole genome sequencing in adults with B-other acute lymphoblastic leukemia
Leongamornlert, D. A., Gutiérrez‐Abril, J., Lee, S., Barretta, E., Creasey, T., Gundem, G., Levine, M. F., Ossa, J. A., Liosis, K., Medina-Martinez, J. S., et al. (2023) · Blood Advances · doi:10.1182/bloodadvances.2022008992 · Cited by 28
Self-citationThe DNA methylation landscape of primary triple-negative breast cancer
Aine, M., Nacer, D. F., Arbajian, E., Veerla, S., Karlsson, A., Häkkinen, J., Johansson, H. J., Rosengren, F., Vallon‐Christersson, J., Borg, Å., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58158-x · Cited by 33
Self-citationFrequent mutation of the FOXA1 untranslated region in prostate cancer
Annala, M., Taavitsainen, S., Vandekerkhove, G. R., Bacon, J. V. W., Beja, K., Chi, K. N., Nykter, M., & Wyatt, A. W. (2018) · Communications Biology · doi:10.1038/s42003-018-0128-1 · Cited by 29
Complex structural rearrangements are present in high-grade dysplastic Barrett’s oesophagus samples
Newell, F., Patel, K., Gartside, M. G., Krause, L., Brosda, S., Aoude, L. G., Loffler, K. A., Bonazzi, V., Patch, A., Kazakoff, S. H., et al. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0476-9 · Cited by 29
Hidden Markov models lead to higher resolution maps of mutation signature activity in cancer
Huang, X., Sason, I., Wójtowicz, D., Kim, Y.-A., Leiserson, M. D. M., Przytycka, T. M., & Sharan, R. (2019) · Genome Medicine · doi:10.1186/s13073-019-0659-1 · Cited by 27
Splicing regulatory factors in breast cancer hallmarks and disease progression
Koedoot, E., Wolters, L., van de Water, B., & Dévédec, S. E. L. (2019) · Oncotarget · doi:10.18632/oncotarget.27215 · Cited by 28
Kim, S.-S., Lee, M. H., & Lee, M. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-019-05517-0 · Cited by 29
Li, B., Li, T., Liu, J. S., & Liu, X. S. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0327-7_18 · Cited by 29
Research advances and new challenges in overcoming triple-negative breast cancer
Zong, Y., & Pegram, M. D. (2021) · Cancer Drug Resistance · doi:10.20517/cdr.2021.04 · Cited by 29
Recombination and restart at blocked replication forks
Scully, R., Elango, R., Panday, A., & Willis, N. A. (2021) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2021.08.003 · Cited by 29
Vafaizadeh, V., Buechel, D., Rubinstein, N., Kalathur, R. K. R., Bazzani, L., Saxena, M. T., Valenta, T., Hausmann, G., Cantù, C., Basler, K., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02016-9 · Cited by 29
Fusion‐associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance
Loo, S. K., Yates, M. E., Yang, S., Oesterreich, S., Lee, A. V., & Wang, X. (2022) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23029 · Cited by 28
HER2-driven breast cancer suppression by the JNK signaling pathway
Itah, Z., Chaudhry, S., Ponny, S. R., Aydemir, Ö., Lee, A., Cavanagh, J., Tournier, C., Muller, W. J., & Davis, R. J. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2218373120 · Cited by 28
Tsang, E. S., Csizmók, V., Williamson, L. M., Pleasance, E., Topham, J. T., Karasinska, J. M., Titmuss, E., Schrader, K. A., Yip, S. S. F., Tessier‐Cloutier, B., et al. (2023) · npj Precision Oncology · doi:10.1038/s41698-023-00368-x · Cited by 26
Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response
Lee, R. S., Sad, K., Fawwal, D. V., & Spangle, J. M. (2023) · Cancers · doi:10.3390/cancers15154005 · Cited by 29
Wang, S., Liu, J. C., Ju, Y., Pellecchia, G., Voisin, V., Wang, D., l, R. L., Ben‐David, Y., Bader, G. D., & Zacksenhaus, E. (2017) · JCI Insight · doi:10.1172/jci.insight.93313 · Cited by 28
Self-citationZapata, L., Sušak, H., Drechsel, O., Friedländer, M. R., Estivill, X., & Ossowski, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-12888-1 · Cited by 29
Elucidating therapeutic molecular targets in premenopausal Asian women with recurrent breast cancers
Yap, Y. S., Singh, A., Lim, J. H. C., Ahn, J., Jung, K.-H., Kim, J., Dent, R. A., Ng, R. C. H., Kim, S., & Chiang, D. Y. (2018) · npj Breast Cancer · doi:10.1038/s41523-018-0070-x · Cited by 28
CRISPR Diagnosis and Therapeutics with Single Base Pair Precision
Lee, S. H., Park, Y., Jin, Y. B., Kim, S., & Hur, J. K. (2019) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.09.008 · Cited by 29
Replication Fork Remodeling and Therapy Escape in DNA Damage Response-Deficient Cancers
Liptay, M., Barbosa, J. S., & Rottenberg, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00670 · Cited by 30
Brunner, A., Rahmanto, A. S., Johansson, H. J., Franco, M., Viiliäinen, J., Gazi, M., Frings, O., Fredlund, E., Spruck, C., Lehtiö, J., et al. (2020) · eLife · doi:10.7554/elife.57894 · Cited by 29
Correlation of NUF2 Overexpression with Poorer Patient Survival in Multiple Cancers
Jiang, X., Jiang, Y., Luo, S., Sekar, K., Koh, C. K. T., Deivasigamani, A., Dong, Q., Zhang, N., Li, S., Hao, F., et al. (2021) · Cancer Research and Treatment · doi:10.4143/crt.2020.466 · Cited by 28
Hussain, S. S., Majumdar, R., Moore, G. M., Narang, H., Buechelmaier, E. S., Bazil, M. J., Ravindran, P. T., Leeman, J. E., Li, Y., Jalan, M., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab262 · Cited by 28
Self-citationKarpinets, T. V., Mitani, Y., Liu, B., Zhang, J., Pytynia, K. B., Sellen, L. D., Karagiannis, D. T., Ferrarotto, R., Futreal, P. A., & El‐Naggar, A. K. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4071 · Cited by 28
Self-citationTargeting Mutated p53 Dependency in Triple-Negative Breast Cancer Cells Through CDK7 Inhibition
Peng, J., Yang, M. W., Bi, R., Wang, Y., Wang, C., Wei, X., Zhang, Z., Xie, X., & Wei, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.664848 · Cited by 28
King, J. J., Borzooee, F., Im, J., Asgharpour, M., Ghorbani, A., Diamond, C. P., Fifield, H., Berghuis, L., & Larijani, M. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00091 · Cited by 29
Hamdan, A., & Ewing, A. (2022) · The Journal of Pathology · doi:10.1002/path.5901 · Cited by 29
Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma
Abbas, S., Pich, O., Devonshire, G., Zamani, S. A., Katz‐Summercorn, A., Killcoyne, S., Cheah, C., Nutzinger, B., Grehan, N., López-Bigas, N., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39957-6 · Cited by 28
Song, X.-H., Yang, L., Zheng, X., Zhu, Q., Liao, X.-L., Liu, K., Zhang, W., Peng, Q., Zhu, Y., Zhao, L.-Y., et al. (2023) · MedComm · doi:10.1002/mco2.342 · Cited by 28
Georgakopoulos‐Soares, I., Koh, C. C., Momen, S., Jiricny, J., Hemberg, M., & Nik‐Zainal, S. (2020) · Nature Communications · doi:10.1038/s41467-020-15901-w · Cited by 25
Self-citationChandarlapaty, S., & Razavi, P. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.19.00090 · Cited by 29
RAD52 resolves transcription-replication conflicts to mitigate R-loop induced genome instability
Jalan, M., Sharma, A., Pei, X., Weinhold, N., Buechelmaier, E. S., Zhu, Y., Ahmed‐Seghir, S., Ratnakumar, A., Bona, M. D., McDermott, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51784-x · Cited by 29
Genomic hallmarks of endocrine therapy resistance in ER/PR+HER2- breast tumours
Ghosh, A., Chaubal, R., Das, C., Parab, P. A., Das, S. K., Maitra, A., Majumder, P. P., Gupta, S., & Biswas, N. K. (2025) · Communications Biology · doi:10.1038/s42003-025-07606-x · Cited by 31
Yang, C., Tang, H., Wang, L., Peng, R., Bai, F., Shan, Y., Yu, Z.-Y., Zhou, P., & Cong, Y. (2018) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2018.07.2010 · Cited by 27
Yoshino, Y., Endo, S., Chen, Z., Qi, H., Watanabe, G., & Chiba, N. (2019) · Scientific Reports · doi:10.1038/s41598-018-38311-x · Cited by 28
Wang, S., Pitt, J. J., Zheng, Y., Yoshimatsu, T. F., Gao, G., Sanni, A., Oluwasola, O., Ajani, M., Fitzgerald, D., Odetunde, A., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32498 · Cited by 27
Xing, X., Mu, N., Yuan, X., Wang, N., Juhlin, C. C., Strååt, K., Larsson, C., & Xu, D. (2020) · Cancers · doi:10.3390/cancers12082133 · Cited by 27
Next-Generation Analytics for Omics Data
Li, J., Chen, H., Wang, Y., Chen, M.-J. M., & Liang, H. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.09.002 · Cited by 28
The Genomic Landscape of Lobular Breast Cancer
Reed, A. E. M., Foong, S., Kutasovic, J. R., Nones, K., Waddell, N., Lakhani, S. R., & Simpson, P. T. (2021) · Cancers · doi:10.3390/cancers13081950 · Cited by 27
Self-citationThe landscape and driver potential of site-specific hotspots across cancer genomes
Juul, R. I., Nielsen, M. M., Juul, M., Feuerbach, L., & Pedersen, J. S. (2021) · npj Genomic Medicine · doi:10.1038/s41525-021-00197-6 · Cited by 29
Dióssy, M., Sztupinszki, Z. M., Börcsök, J., Krzystanek, M., Tisza, V., Spisák, S., Rusz, O., Tı́már, J., Csabai, I., Fillinger, J., et al. (2021) · npj Precision Oncology · doi:10.1038/s41698-021-00199-8 · Cited by 27
An overview of mutational and copy number signatures in human cancer
Steele, C. D., Pillay, N., & Alexandrov, L. B. (2022) · The Journal of Pathology · doi:10.1002/path.5912 · Cited by 27
Self-citationKostecka, A., Nowikiewicz, T., Olszewski, P., Koczkowska, M., Horbacz, M., Heinzl, M., Andreou, M., Salazar, R., Mair, T., Madanecki, P., et al. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00443-9 · Cited by 27
Self-citationDNA nicks induce mutational signatures associated with BRCA1 deficiency
Feng, Y.-L., Liu, Q., Chen, R.-D., Liu, S., Huang, Z., Liu, K.-M., Yang, X., & Xie, A. (2022) · Nature Communications · doi:10.1038/s41467-022-32011-x · Cited by 30
Patterns of structural variation define prostate cancer across disease states
Zhou, M., Ko, M., Hoge, A. C. H., Luu, K., Liu, Y., Russell, M. L., Hannon, W. W., Zhang, Z., Carrot‐Zhang, J., Beroukhim, R., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.161370 · Cited by 26
Schwartz, C. J., Ruiz, J., Bean, G. R., Sirohi, D., Joseph, N. M., Hosfield, E. M., Jacobs, T. W., Mukhtar, R. A., Chen, Y., & Krings, G. (2023) · Modern Pathology · doi:10.1016/j.modpat.2023.100125 · Cited by 27
Metadata
- Authors
- Nik-Zainal, S., Davies, H., Staaf, J., Ramakrishna, M., Glodzik, D., Zou, X., Martincorena, I., Alexandrov, L. B., Martin, S., Wedge, D. C., Van Loo, P., Ju, Y. S., Smid, M., Brinkman, A. B., Morganella, S., Aure, M. R., Lingjærde, O. C., Langerød, A., Ringnér, M., Ahn, S.-M., Boyault, S., Brock, J. E., Broeks, A., Butler, A., Desmedt, C., Dirix, L., Dronov, S., Fatima, A., Foekens, J. A., Gerstung, M., Hooijer, G. K. J., Jang, S. J., Jones, D. R., Kim, H.-Y., King, T. A., Krishnamurthy, S., Lee, H. J., Lee, J.-Y., Li, Y., McLaren, S., Menzies, A., Mustonen, V., O’Meara, S., Pauporté, I., Pivot, X., Purdie, C. A., Raine, K., Ramakrishnan, K., Rodríguez-González, F. G., Romieu, G., Sieuwerts, A. M., Simpson, P. T., Shepherd, R., Stebbings, L., Stefansson, O. A., Teague, J., Tommasi, S., Treilleux, I., Van den Eynden, G. G., Vermeulen, P., Vincent-Salomon, A., Yates, L., Caldas, C., Veer, L. V., Tutt, A., Knappskog, S., Tan, B. K. T., Jonkers, J., Borg, Å., Ueno, N. T., Sotiriou, C., Viari, A., Futreal, P. A., Campbell, P. J., Span, P. N., Van Laere, S., Lakhani, S. R., Eyfjord, J. E., Thompson, A. M., Birney, E., Stunnenberg, H. G., van de Vijver, M. J., Martens, J. W. M., Børresen-Dale, A.-L., Richardson, A. L., Kong, G., Thomas, G., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- Lund University (SE)
- Los Alamos National Laboratory (US)
- Erasmus MC (NL)
- Radboud University Nijmegen (NL)
- European Bioinformatics Institute (GB)
- Oslo University Hospital (NO)
- University of Oslo (NO)
- Gachon University Gil Medical Center (KR)
- Centre Léon Bérard (FR)
- Brigham and Women's Hospital (US)
- The Netherlands Cancer Institute (NL)
- Université Libre de Bruxelles (BE)
- University of Antwerp (BE)
- Dana-Farber Cancer Institute (US)
- Amsterdam UMC Location University of Amsterdam (NL)
- Asan Medical Center (KR)
- Hanyang University (KR)
- Memorial Sloan Kettering Cancer Center (US)
- The University of Texas MD Anderson Cancer Center (US)
- Institut National du Cancer (FR)
- Inserm (FR)
- Ninewells Hospital (GB)
- Institut Regional du Cancer de Montpellier (FR)
- The University of Queensland (AU)
- Istituto Tumori Bari (IT)
- University of Cambridge (GB)
- Institute of Cancer Research (GB)
- Haukeland University Hospital (NO)
- Singapore General Hospital (SG)
- Institut national de recherche en sciences et technologies du numérique (FR)
- Radboud University Medical Center (NL)
- University of Iceland (IS)
- Corresponding author
- Viari, Alain
- Kong, Gu
- Stratton, Michael R.
- ORCID
- Davies, Helen
- Staaf, Johan
- Ramakrishna, Manasa
- Zou, Xueqing
- Alexandrov, Ludmil B.
- Martin, Sancha
- Wedge, David C.
- Ju, Young Seok
- Smid, Marcel
- Brinkman, Arie B.
- Morganella, Sandro
- Aure, Miriam R.
- Lingjærde, Ole Christian
- Ringnér, Markus
- Ahn, Sung-Min
- Boyault, Sandrine
- Brock, Jane E.
- Broeks, Annegien
- Desmedt, Christine
- Dirix, Luc
- Dronov, Serge
- Gerstung, Moritz
- Hooijer, Gerrit K. J.
- Jang, Se Jin
- Jones, David R.
- Krishnamurthy, Savitri
- Lee, Hee Jin
- Lee, Jeong-Yeon
- Li, Yilong
- McLaren, Stuart
- Menzies, Andrew
- Mustonen, Ville
- Pivot, Xavier
- Purdie, Colin A.
- Raine, Keiran
- Ramakrishnan, Kamna
- Rodríguez-González, F. Germán
- Sieuwerts, Anieta M.
- Simpson, Peter T.
- Shepherd, Rebecca
- Teague, Jon
- Tommasi, Stefania
- Treilleux, Isabelle
- Vermeulen, Peter
- Yates, Lucy
- Caldas, Carlos
- Veer, Laura van’t
- Tutt, Andrew
- Knappskog, Stian
- Tan, Benita Kiat Tee
- Jonkers, Jos
- Borg, Åke
- Ueno, Naoto T.
- Sotiriou, Christos
- Viari, Alain
- Futreal, P. Andrew
- Span, Paul N.
- Lakhani, Sunil R.
- Thompson, Alastair M.
- Birney, Ewan
- Stunnenberg, Hendrik G.
- Martens, John W. M.
- Richardson, Andrea L.
- Kong, Gu
- Thomas, Gilles
- Stratton, Michael R.
- Venue
- Nature
- Published
- 2016-05-02
- Volume
- 534
- Issue
- 7605
- Pages
- 47-54
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4910866
- OpenAlex
- W2344657883
- Semantic Scholar
- abb27e35f11dcd60325f42f270b7811a4e852852
- Cited by
- 2,218
- References
- 60
- Citations by year
- 2026: 125 · 2025: 147 · 2024: 178 · 2023: 271 · 2022: 212 · 2021: 293 · 2020: 288 · 2019: 241 · 2018: 200 · 2017: 181 · 2016: 78
- FWCI
- 97.22
- Type
- journal article
- Language
- en
- Update notices
- correction (2019-01-18)
- Open access
- green
- pure.amsterdamumc.nl
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Pure Amsterdam UMC (acceptedVersion, other-oa)
- PubMed Central (acceptedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
- HAL (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Discovery Research Portal (University of Dundee) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion)
- Lirias (KU Leuven) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- RePub (Erasmus University Rotterdam) (submittedVersion)
- Apollo
- Funders
- U.S. Department of Energy (DE-AC52-06NA2-5396, AC52-06NA25396)
- Breast Cancer Research Foundation
- Dana-Farber/Harvard Cancer Center (P50 CA168504)
- University of Dundee
- Wellcome Trust (088177, 077012/Z/05/Z, 100183, 077012, WT100183MA, 098051)
- Francis Crick Institute (10202)
- QIMR Berghofer Medical Research Institute
- Cancer Research UK (60098573, 20952, CB4140, 16942)
- National Institute for Health and Care Research (NF-SI-0515-10090, NF-SI-0611-10154)
- Breast Cancer Campaign
- University of Cambridge
- European Commission (242006)
- National Research Foundation
- Icelandic Centre for Research
- Fonds De La Recherche Scientifique - FNRS
- Cancerfonden
- Cambridge University Hospitals (RG51913)
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- National Research Foundation of Korea (2015R1A2A1A10052578, 2011-0030105)
- Vetenskapsrådet
- Háskóli Íslands
- Institut National Du Cancer
- Rannís
- National Institutes of Health (DE-AC52-06NA25396)
- National Nuclear Security Administration (DEAC52- 06NA25396)
- National Cancer Institute (CA168504, P30CA008748, P50CA168504)
- Los Alamos National Laboratory (AC52-06NA25396, DE-AC52-06NA25396)
- FP7 Ideas: European Research Council (322737)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- breast cancer, somatic mutations, driver mutations, mutational signatures, tandem duplication, homologous recombination deficiency, BRCA1, BRCA2, non-coding regions, intronic variants
- MeSH terms
- Breast Neoplasms, DNA Mutational Analysis, DNA Replication, DNA, Neoplasm, Female, Humans, Male, Mutation, Oncogenes, Cohort Studies, Genome, Human, Mutagenesis, Genes, BRCA1, Genomics, Genes, BRCA2, Mutation Rate, Recombinational DNA Repair
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
